{"id":6810,"date":"2020-11-19T13:46:22","date_gmt":"2020-11-19T13:46:22","guid":{"rendered":"https:\/\/by-tv.co.uk\/?p=6810"},"modified":"2020-11-19T13:46:22","modified_gmt":"2020-11-19T13:46:22","slug":"oxford-astrazenecanin-kovid-19-asi-adayi-yaslilarda-guclu-bagisiklik-tepkisi-olusturdu","status":"publish","type":"post","link":"https:\/\/by-tv.co.uk\/en\/oxford-astrazenecanin-kovid-19-asi-adayi-yaslilarda-guclu-bagisiklik-tepkisi-olusturdu\/","title":{"rendered":"Oxford-AstraZeneca\u2019n\u0131n Kovid-19 a\u015f\u0131 aday\u0131 ya\u015fl\u0131larda g\u00fc\u00e7l\u00fc ba\u011f\u0131\u015f\u0131kl\u0131k tepkisi olu\u015fturdu"},"content":{"rendered":"

LONDRA(AA) – T\u0131p dergisi Lancet’te, AstraZeneca’n\u0131n Oxford \u00dcniversitesi ile ortakla\u015fa geli\u015ftirdi\u011fi Kovid-19 a\u015f\u0131 aday\u0131na ili\u015fkin yay\u0131mlanan makalede, yakla\u015f\u0131k 560 sa\u011fl\u0131kl\u0131 yeti\u015fkin g\u00f6n\u00fcll\u00fcye, iki doz a\u015f\u0131 veya bir plasebo verilen ikinci faz denemelerinin sonu\u00e7lar\u0131 payla\u015f\u0131ld\u0131.<\/p>\n

A\u015f\u0131n\u0131n birinci ve ikinci a\u015fama denemelerinde, Kovid-19 nedeniyle \u00f6l\u00fcm veya ciddi hastal\u0131k riski bulunan gruplar \u00fczerinde g\u00fc\u00e7l\u00fc ba\u011f\u0131\u015f\u0131kl\u0131k geli\u015ftirdi\u011fi belirtildi.<\/p>\n

\u0130kinci a\u015fama denemelerinde, 18-55, 56-69, 70 ve \u00fcst\u00fc olmak \u00fczere 3 ayr\u0131 ya\u015f grubundaki g\u00f6n\u00fcll\u00fclerin tamam\u0131nda a\u015f\u0131n\u0131n benzer antikor ve T h\u00fccresi tepkileri g\u00f6sterdi\u011fi, g\u00f6n\u00fcll\u00fclerin herhangi bir yan etki bildirmedi\u011fi kaydedildi.<\/p>

\"\"<\/a><\/div>\n

Oxford A\u015f\u0131 Grubu ara\u015ft\u0131rmac\u0131s\u0131 Dr. Maheshi Ramasamy, a\u015f\u0131n\u0131n sadece ya\u015fl\u0131larda de\u011fil gen\u00e7lerde de benzer ba\u011f\u0131\u015f\u0131kl\u0131k tepkileri verdi\u011fini g\u00f6rmekten memnuniyet duyduklar\u0131n\u0131 belirtti.<\/p>\n

AstraZeneca firmas\u0131n\u0131n Oxford \u00dcniversitesi ile vir\u00fcse kar\u015f\u0131 y\u00fcr\u00fctt\u00fc\u011f\u00fc 2. faz a\u015f\u0131 denemelerine eyl\u00fcl ay\u0131 ba\u015f\u0131nda, deneklerden birinde ortaya \u00e7\u0131kan n\u00f6rolojik sorun nedeniyle ABD\u2019de ara verilmi\u015f ancak sorunun Kovid-19 a\u015f\u0131s\u0131ndan kaynaklanmad\u0131\u011f\u0131na karar verilmesinin ard\u0131ndan AstraZeneca’n\u0131n \u00e7al\u0131\u015fmalar\u0131na devam edece\u011fi duyurulmu\u015ftu.<\/p>\n

Moderna ve Pfizer-BioNTech a\u015f\u0131 adaylar\u0131<\/p>\n

Amerikan ila\u00e7 \u015firketi Pfizer ile T\u00fcrk bilim insan\u0131 Prof. Dr. U\u011fur \u015eahin’in kurucu orta\u011f\u0131 oldu\u011fu Alman biyoteknoloji firmas\u0131 BioNTech’in Kovid-19’a kar\u015f\u0131 geli\u015ftirmekte oldu\u011fu potansiyel a\u015f\u0131n\u0131n vir\u00fcse kar\u015f\u0131 y\u00fczde 90’dan fazla etkili oldu\u011fu bildirilmi\u015fti.<\/p>\n

Amerikan biyoteknoloji \u015firketi Moderna’da, hala s\u00fcren \u00e7al\u0131\u015fmalardan elde edilen ilk verilerin, a\u015f\u0131s\u0131n\u0131n y\u00fczde 95,4 etkili oldu\u011funu ortaya koydu\u011funu a\u00e7\u0131klam\u0131\u015ft\u0131.<\/p>\n

Bir a\u015f\u0131n\u0131n yayg\u0131n olarak kullan\u0131labilmesi i\u00e7in 3 a\u015famada insanlar \u00fczerinde test edilmesi gerekiyor.<\/p>\n

Klinik denemelerin ilk a\u015famas\u0131nda, az say\u0131daki g\u00f6n\u00fcll\u00fc sa\u011fl\u0131kl\u0131 denek \u00fczerinde a\u015f\u0131n\u0131n g\u00fcvenli olup olmad\u0131\u011f\u0131 ve insanlar \u00fczerindeki muhtemel yan etkileri ara\u015ft\u0131r\u0131l\u0131yor. \u0130kinci a\u015famada, a\u015f\u0131n\u0131n ba\u011f\u0131\u015f\u0131k tepkilerini uyand\u0131rmadaki etkinli\u011fi 100\u2019den fazla denek \u00fczerinde test ediliyor. \u00dc\u00e7\u00fcnc\u00fc ve son a\u015famada ise ayn\u0131 i\u015flem binlerce denekle tekrarlan\u0131yor. T\u00fcm bu s\u00fcre\u00e7 aylar ve hatta y\u0131llar alabiliyor.<\/p>\n

\"\"<\/a><\/div>","protected":false},"excerpt":{"rendered":"

LONDRA(AA) – T\u0131p dergisi Lancet’te, AstraZeneca’n\u0131n Oxford \u00dcniversitesi ile ortakla\u015fa geli\u015ftirdi\u011fi Kovid-19 a\u015f\u0131 aday\u0131na ili\u015fkin yay\u0131mlanan makalede, yakla\u015f\u0131k 560 sa\u011fl\u0131kl\u0131 yeti\u015fkin g\u00f6n\u00fcll\u00fcye, iki doz a\u015f\u0131 veya bir plasebo verilen ikinci faz denemelerinin sonu\u00e7lar\u0131 payla\u015f\u0131ld\u0131. A\u015f\u0131n\u0131n birinci ve ikinci a\u015fama denemelerinde, Kovid-19 nedeniyle \u00f6l\u00fcm veya ciddi hastal\u0131k riski bulunan gruplar \u00fczerinde g\u00fc\u00e7l\u00fc ba\u011f\u0131\u015f\u0131kl\u0131k geli\u015ftirdi\u011fi belirtildi. \u0130kinci a\u015fama denemelerinde, 18-55, 56-69, 70 ve \u00fcst\u00fc olmak \u00fczere 3 ayr\u0131 ya\u015f grubundaki g\u00f6n\u00fcll\u00fclerin tamam\u0131nda a\u015f\u0131n\u0131n benzer antikor ve T h\u00fccresi tepkileri g\u00f6sterdi\u011fi, g\u00f6n\u00fcll\u00fclerin herhangi bir yan etki bildirmedi\u011fi kaydedildi. Oxford A\u015f\u0131 Grubu ara\u015ft\u0131rmac\u0131s\u0131 Dr. Maheshi Ramasamy, a\u015f\u0131n\u0131n sadece ya\u015fl\u0131larda de\u011fil gen\u00e7lerde de benzer ba\u011f\u0131\u015f\u0131kl\u0131k […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-6810","post","type-post","status-publish","format-standard","hentry","category-ingiltere"],"_links":{"self":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/6810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/comments?post=6810"}],"version-history":[{"count":0,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/6810\/revisions"}],"wp:attachment":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media?parent=6810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/categories?post=6810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/tags?post=6810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}